Board of Directors

David R. Bethune

Mr. Bethune has served as our  Executive Chairman since August 2007. He has been a member of the board since 2005 and was appointed chairman on May 21, 2007. He is also a member of the Board of Cambrex Corporation. From 1999 until his retirement, he was Chairman and Chief Executive Officer of Atrix Laboratories, a drug delivery and product development company. Prior to Atrix Laboratories, he was President and Chief Operating Officer of IVAX Corporation, a pharmaceutical company. Before joining IVAX, Mr. Bethune began a start-up pharmaceutical company venture formed by Mayo Medical Ventures, a business unit of Mayo Clinics of Rochester. Mr. Bethune previously served as group vice president of American Cyanamid Company and a member of the Executive Committee where he had executive authority for human biologicals, consumer health products, pharmaceuticals and ophthalmics as well as global medical research. He was also President of the Lederle Laboratories Division of American Cyanamid Company. Mr. Bethune received a B.A. degree in accounting and economics from Lenior-Rhyne College, Hickory, North Carolina and Masters in Business Administration in the Executive Program from Columbia University Graduate School.

J. Steven Garrett, MS, DDS, FACD

Dr. Garrett has more than 30 years of experience in broad healthcare areas.  He served as senior vice president clinical research for QLT USA, Inc., where, among other responsibilities, he managed all of that company’s clinical trials, interfaced with the FDA and coordinated the clinical portion of regulatory submissions.  Previously, Dr. Garrett served as chairman of the department of periodontics at Loma Linda University as well as director of the advanced education program in periodontics and implant dentistry.  Earlier, he owned and operated a private dentistry practice, specializing in periodontics and implant dentistry.

Leslie H. Green

Since 1998, Ms. Green has been Managing Partner of Roffe & Green, Inc., which provides interim management and business development consulting services, with particular emphasis on healthcare, consumer products and services. Since co- founding Roffe & Green, she has served as a consultant or in various full and part-time interim management positions for several businesses in multiple industries, including Chief Marketing Officer of The French Culinary Institute and Vice President of Marketing of Aurora Imaging Technology. From January 1999 to March 2001 Ms. Green served as interim Chief Executive Officer and President of Nydic, Inc., a medical diagnostic imaging company. Prior to her election to the Board of ZILA, she provided consulting services as interim General Manager and interim National Sales Manager of Zila Pharmaceuticals, Inc. from July 2003 to March 2004.

O.B. Parrish

Mr. Parrish is the Chairman and CEO of the Female Health Company, the developer of the first female condom.  In collaboration with the World Health Organization, the United Nations Joint Program on AIDS and other public sector groups, the FC Female Condom is distributed worldwide as part of HIV/AIDS prevention programs.  Mr. Parrish is also the President of Phoenix Health Care of Illinois, Inc. a private company which invests in innovative healthcare opportunities.  In addition, Mr. Parrish is the Chairman of Abiant, Inc. of Chicago, which provides proprietary neuroimaging technology to the pharmaceutical industry for use in selecting and developing new drugs. 

Earlier in his career Mr. Parrish was the President of the Pharmaceutical Group of G.D. Searle in Chicago where he was responsible for its global pharmaceutical business.  Prior to joining Searle, Mr. Parrish was Executive Vice President of the International Division of Pfizer, Inc, in New York.  Other positions held at Pfizer included Executive Vice President of Pfizer Pharmaceuticals, Division Manager and Vice President, Marketing of Pfizer Laboratories.

Mr. Parrish holds a B.S degree from Lawrence University and an M.B.A. degree from the University of Chicago.  Mr. Parrish is also a trustee of Lawrence University.

George J. Vuturo, PhD

Dr. Vuturo, 57, has over 28 years of experience in the pharmaceuticals industry and is recognized as a leader in the field of medical education technology.  In 1995, Dr. Vuturo founded Designing Solutions, L.L.C. and Professional Education Services Group, L.L.C., both are healthcare services companies that specialize in providing professional medical education programs to physicians, pharmacists, dentists, nurses, and other healthcare providers. Dr. Vuturo has served as managing partner of both companies since their inception.  From 2004 to 2005, Dr. Vuturo was a member of the Board of Directors of QLT, Inc., a publicly-traded biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies.  From 2001 to 2004, Dr. Vuturo was a member of the Board of Directors and, at various times, served on the Executive, Compensation, Audit and Nominations Committees of Atrix Laboratories, Inc. Atrix Laboratories, a former publicly-traded specialty pharmaceutical company, is focused on advanced drug delivery.  In 2005, Atrix Laboratories merged with QLT, Inc.  Dr. Vuturo received his Ph.D. in Health Care Administration from the University of Florida , where he also received his Bachelor of Science in Pharmacy.  Additionally, Dr. Vuturo holds a B.S. in Biology from Fairfield University .